Skip to main content

Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients

Research Authors
Asmaa M. Zahran, Mona H. Abdel-Rahim, Khalid A. Nasif, Safinaz Hussein, Rania Hafez, Ahmad Bahieldeen Ahmad, Khaled Saad, Amira Elhoufey, Hosni A. M. Hussein, Ali A. Thabet, Omnia El-Badawy
Research Date
Research Department
Research Journal
Virulence
Research Publisher
Taylor and Francis
Research Vol
13 (1)
Research Website
https://www.tandfonline.com/doi/citedby/10.1080/21505594.2022.2047506?scroll=top&needAccess=true
Research Year
2022
Research_Pages
569-577
Research Abstract

We aimed to determine the levels of follicular helper T (Tfh) and follicular regulatory T (Tfr) cells in COVID-19 patients and determine whether their levels correlated with disease severity and presence of hyperglycemia. This study was carried out in 34 hospitalized COVID-19 patients and 20 healthy controls. Levels of total circulating Tfh, inducible T-cell costimulator (ICOS)+ activated Tfh, and Tfr cells were assessed in all participants by flow cytometry. Total CD4+CXCR5+ Tfh cells and ICOS+Foxp3-activated Tfh cells increased and ICOS+Foxp3+ Tfr cells decreased in COVID-19 patients, especially in diabetic patients and those with severe disease. Activated ICOS+ Tfh cells were directly correlated with lactate dehydrogenase, D-dimer, ferritin, and respiratory rate and inversely correlated with the partial pressure of carbon dioxide. COVID-19 is associated with marked activation of Tfh cells and a profound drop in Tfr cells, especially in severe and diabetic patients. Future studies on expanded cohorts of patients are needed to clarify the relationship between SARS-CoV-2 and acute-onset diabetes.